188 filings
Page 5 of 10
8-K
iczgldds93vud
15 Feb 19
Marker Therapeutics Announces Change in Corporate Headquarters and Access to New Laboratory Facility
4:55pm
8-K
a2h16zoljs6gwv4xwy
15 Jan 19
Present at the Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR 2019
5:15pm
8-K
5ul5y60
4 Jan 19
Marker Therapeutics Provides Updates of its Lead Clinical Programs
12:34pm
8-K
odabdz
4 Dec 18
Other Events
12:00am
8-K
yap9vbbp1q r9ygeq
3 Dec 18
Departure of Directors or Certain Officers
4:12pm
8-K
c5tbixlhlkgv0q
27 Nov 18
The Center for Cell and Gene Therapy at Baylor College of Medicine to Present at the 60th American Society of Hematology Annual Meeting
4:58pm
8-K
cjggxm0pttx65qvq7h4
27 Nov 18
Marker Therapeutics, Inc. Appoints Anthony H. Kim as Chief Financial Officer
9:15am
8-K
hm9n23 9qbm5p
30 Oct 18
Other Events
4:18pm
8-K/A
fxnxq3zshb0aetv3g
29 Oct 18
Financial Statements and Exhibits
12:00am
8-K
p9ksc3ppm1do7ola9g7d
23 Oct 18
Marker Therapeutics, Inc. Announces New Executive Appointments
5:08pm
8-K
ew42kncb
17 Oct 18
Tapimmune and Marker Therapeutics Announce Successful Closing of Previously Announced Merger and Financing
4:00pm
8-K
aqloe
8 Aug 18
Other Events
4:40pm
8-K
7b4 f0i007
8 Jun 18
TapImmune Announces Pricing of $70 Million Private Placement
9:21am
8-K
fidl1u6 dl2zkm
18 May 18
Entry into a Material Definitive Agreement
5:16pm
8-K
ragke
15 May 18
TapImmune and Marker Therapeutics Announce Entry into Merger Agreement, Creating a Transformational Immuno-Oncology Platform
6:07am
8-K
rjvwq
25 Sep 17
TapImmune Appoints Peter Hoang as President and Chief Executive Officer
12:00am
8-K
0rqgj3pk q7qft
5 Sep 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
j8g91kbew rk1f8f
11 Jul 17
Departure of Directors or Certain Officers
12:00am
8-K
k27c z0dm
26 Jun 17
Unregistered Sales of Equity Securities
12:00am
8-K
7s9mvmje
22 Jun 17
TapImmune Inc. Enters into Definitive Agreements to Raise
12:00am